Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces that it has appointed Didier Le Normand as Group CFO as well as General Manager of its...
Read moreUsher syndrome is a genetic disorder that presents recessive inheritance and is characterized by hearing loss and retinitis pigmentosa, traits that may be total or partial.
Read moreResults could help remove one of the barriers to treatment scale up and bring new hope for people with Chagas disease
Read moreFor the third year in a row, the Leo Messi Foundation has renewed its collaboration with the Translational Research in Child and Adolescent Cancer group of the Vall d'Hebron Research Institute (VHIR)
Read moreEl CIBERER ha liderado o participado en las 15 designaciones de medicamentos huérfanos de centros públicos españoles. Los grupos de este centro investigan en terapias para grupos de enfermedades co...
Read moreLa UIB ha liderado el mayor ensayo clínico acerca de los efectos de diferentes estrategias nutricionales en la prevención del Trastorno Depresivo Mayor
Read moreUn estudio de la Universidad Pompeu Fabra revela nuevas interacciones entre lenguaje y pensamiento en la afasia, un trastorno del lenguaje que se produce como consecuencia de un accidente cerebrovascu...
Read moreSilvia Vicente, nurse at the Neonatal Intensive Care Unit (NICU) in San Pablo and member of the Care Research Group at the Sant Pau Biomedical Research Institute (IIB Sant Pau), has devised a device, ...
Read moreUna terapia basada en linfocitos modificados genéticamente ha mostrado resultados prometedores en un modelo de lupus eritematoso en ratón. La terapia, dirigida a eliminar los linfocitos B y minimiza...
Read moreResearchers from IDIBELL and ICO show that current mutational analysis techniques are sufficiently sensitive to predict resistance to treatment with EGFR inhibitors in metastatic colorectal cancer
Read morePeptomyc S.L., spin-off nacida del VHIO, ha producido Omomyc, la miniproteína inhibidora de Myc, y demostrado su actividad antitumoral tras administrarla por vía sanguínea por primera vez. El estud...
Read moreEnantia, a company with headquarters in the Barcelona Science Park and specialised in R&D process chemistry, solid form development and medicinal chemistry, has again succeeded in applying cocrystalli...
Read more